| PUBCHEM ID |
90478687
|
| UNII |
XNV41EX533
|
| Preferred Term |
N4-.BETA.-D-GLUCOSYLSULFANILAMIDE 2,3,4,6-TETRAACETATE
|
| CAS |
894412-68-1
|
| INCHIKEY |
WDIKLYNIKGKLIA-OUUBHVDSSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC(OC[C@@H]([C@@H]([C@H]([C@@H]1OC(C)=O)OC(C)=O)OC(C)=O)O[C@@H]1Nc(cc1)ccc1S(N)(=O)=O)=O
|
| Total Surface Area |
354,62
|
| Relative PSA |
0,44405
|
| TPSA |
195
|
| cLogS |
-2,787
|
| MW |
502,495
|
| cLogP |
-0,256
|
| H-Acceptors |
13
|
| H-Donors |
2
|
| Ro5 violations |
2
|
| Druglikeness |
3,3276
|
| DrugScore |
0,695375701709413
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,3886
|
| P-glycoprotein Substrate |
Non-substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,3868
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,2786
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,2515
|
| Carcinogenicity (Three-class) |
Non-required
|
